![]() |
市場調查報告書
商品編碼
2029994
微創手術器材市場-全球產業規模、佔有率、趨勢、競爭格局、機會、預測:按類型、手術類型、最終用戶、地區和競爭格局分類,2021-2031年Minimally Invasive Surgical Devices Market - Global Industry Size, Share, Trends, Competition, Opportunity, and Forecast, Segmented By Type, By Surgery Type, By End User, By Region & Competition, 2021-2031F |
||||||
全球微創手術器材市場預計將從 2025 年的 257.3 億美元成長到 2031 年的 363.1 億美元,複合年成長率為 5.91%。
這些專用儀器和系統能夠透過極小的切口進行醫療手術,與傳統開放性手術相比,圖降低感染風險、加快癒合速度並減輕患者負擔。市場擴張的主要驅動力是全球範圍內需要手術治療的慢性疾病盛行率不斷上升,以及患者因手術不適感減輕和住院時間縮短而獲得的益處。此外,持續的技術創新,特別是先進影像技術和機器人輔助平台的創新,顯著提高了手術精度,並拓展了可進行的手術範圍。
| 市場概覽 | |
|---|---|
| 預測期 | 2027-2031 |
| 市場規模:2025年 | 257.3億美元 |
| 市場規模:2031年 | 363.1億美元 |
| 複合年成長率:2026-2031年 | 5.91% |
| 成長最快的細分市場 | 消化器官系統 |
| 最大的市場 | 北美洲 |
根據歐洲醫療技術協會(MedTech Europe)的報告,歐洲醫療技術產業(隸屬於更廣泛的醫療保健技術產業)在2024年市場規模將達到約1,700億歐元。儘管該行業發展迅速,但由於實施先進的微創手術系統需要巨額的前期投資,因此這些系統的廣泛應用受到阻礙,這對全球許多醫療機構構成了重大的財務障礙。
全球慢性病激增是推動全球微創手術器材市場發展的主要動力,因為這些疾病通常需要手術治療。糖尿病、心血管疾病和各種癌症等疾病負擔的加重,加速了人們對微創手術的需求,以加速患者康復並減輕疼痛。國際糖尿病聯盟(IDF)發布的《2025年糖尿病地圖集》也印證了這一趨勢:到2024年,全球約有5.89億成年人將患有糖尿病,而糖尿病常常會導致併發症,需要手術干預。慢性病的增加自然擴大了需要手術治療的患者群體,並推動了對能夠縮短康復時間和住院時間的技術的研發。
此外,外科器械技術的持續進步也正在推動市場成長。這提高了手術精度,並擴大了微創技術的應用範圍。先進的可視化技術和機器人輔助系統的進步使醫療專業人員能夠以更高的精度和更輕的體力負擔完成複雜的手術。例如,Intuitive公司於2025年1月發布的第四季快報數據顯示,2024年全球整體達文西手術的數量增加了約17%,顯示人們對手術機器人的依賴程度日益提高。這些創新提高了臨床成功率,並推動了整個醫療技術產業的發展。美國醫療器材促進協會(AdvaMed)的報告也印證了這一點,該報告指出,2024年美國醫療科技產業的年產值將超過2,500億美元。
全球微創手術器械市場擴張的主要障礙之一是購買專用手術系統所需的高前期成本。這一沉重的經濟負擔對全球醫療機構,尤其是發展中地區預算緊張的診所和小規模醫院而言,構成了重大障礙。高昂的前期成本往往導致採購決策的延遲,甚至完全放棄採用最先進的微創手術器械,這限制了這些先進手術技術的廣泛應用。
這些巨額資金需求直接導致技術普及速度放緩,患者獲得高效外科治療的機會也受到限制。先進平台的高昂價格直接反映了其研發所需的巨大投入。正如美國醫療器材協會(AdvaMed)所指出的,美國醫療科技公司在2024年投入至少226億美元用於研發,凸顯了開發這些設備所耗費的巨額資源。這些高昂的研發成本往往轉化為高昂的售價,對醫療服務提供者造成了持續的經濟障礙,並限制了微創手術器材市場的整體成長。
將人工智慧 (AI) 整合到手術器械和術前準備流程中,是重塑微創手術器械產業的關鍵趨勢。 AI 系統分析大量數據,制定術前策略,並在手術過程中提供即時支援,從而提高手術精度,實現更有效率的工作流程和更優的臨床效果。這種變革超越了簡單的自動化,將認知功能引入手術流程,從而實現以患者為中心的治療和更聰明的臨床決策。作為這一前沿領域的領先企業,美敦力公司 (Medtronic plc) 於 2025 年 9 月宣布,將把其倫敦團隊擴充至 200 多人,並建立全球最大的專注於手術機器人和人工智慧的數位化中心。
同時,擴增實境(AR)和3D手術影像技術的進步正在顯著改善醫療專業人員可用的視覺資源。這些創新技術以沉浸式觀點呈現複雜的解剖結構,從而實現高度精準的組織操作和導航,並最大限度地減少創傷。擴增實境平台將關鍵的解剖細節和病患資訊直接疊加到手術視野上,形成抬頭顯示器,減少了外科醫生轉移視線的需要。這種空間感知和視覺清晰度的提升有望提高手術精確度並縮短手術時間。例如,Augmedics公司在2025年4月報告稱,其擴增實境手術導引平台xvision Spine System®已成功治療了10,000名患者。
The Global Minimally Invasive Surgical Devices Market is projected to grow from USD 25.73 Billion in 2025 to USD 36.31 Billion by 2031 at a 5.91% CAGR. These specialized tools and systems allow medical procedures to be performed through tiny incisions, which lowers the risk of infection, accelerates healing, and minimizes patient trauma compared to standard open surgeries. Market expansion is largely driven by the growing worldwide incidence of chronic conditions that require surgical care, coupled with patient advantages like decreased discomfort and abbreviated hospital stays. Additionally, ongoing technological breakthroughs, especially in advanced imaging and robotic-assisted platforms, are greatly improving surgical accuracy and expanding the range of feasible operations.
| Market Overview | |
|---|---|
| Forecast Period | 2027-2031 |
| Market Size 2025 | USD 25.73 Billion |
| Market Size 2031 | USD 36.31 Billion |
| CAGR 2026-2031 | 5.91% |
| Fastest Growing Segment | Gastrointestinal |
| Largest Market | North America |
Operating within the larger healthcare technology sector, the European medical technology industry was valued at roughly €170 billion in 2024, as reported by MedTech Europe. Even with this sector growth, the wider implementation of advanced minimally invasive surgical systems is hindered by the massive initial capital needed for their acquisition, posing a considerable financial obstacle for numerous medical facilities around the world.
Market Driver
The worldwide surge in chronic illnesses is a primary catalyst for the Global Minimally Invasive Surgical Devices Market, given that these ailments often require surgical care. The escalating burden of diseases such as diabetes, cardiovascular issues, and various cancers accelerates the need for procedures that are less intrusive, ensuring faster healing and less physical distress for patients. Highlighting this trend, the International Diabetes Federation (IDF) Diabetes Atlas 2025 indicated that around 589 million adults worldwide had diabetes in 2024, an illness frequently resulting in issues that demand surgical intervention. This rising frequency of chronic diseases naturally broadens the base of individuals needing surgical treatments, fueling a shift toward techniques that reduce both recovery duration and hospital confinement.
Market growth is also stimulated by relentless technological progress in surgical equipment, which refines procedural accuracy and expands the applications of minimally invasive techniques. Breakthroughs in advanced visualization and robotic-assisted systems allow medical professionals to execute intricate surgeries more precisely and with less physical intrusion. Illustrating this rising reliance on surgical robotics, Intuitive's initial fourth-quarter data released in January 2025 showed a roughly 17% global increase in da Vinci procedures during 2024. These innovations elevate clinical success rates and bolster the broader healthcare technology industry, which is underscored by AdvaMed's report that the U.S. medtech sector generated an annual output exceeding $250 billion in 2024.
Market Challenge
A significant obstacle hindering the expansion of the global minimally invasive surgical devices market is the massive initial funding necessary to purchase specialized surgical systems. This steep economic requirement acts as a major hurdle for medical facilities across the globe, especially for budget-limited clinics in developing areas or smaller hospitals. The prohibitive upfront costs frequently result in postponed purchasing decisions or an outright failure to integrate cutting-edge minimally invasive tools, ultimately limiting the widespread availability of these advanced procedures.
The immediate result of these heavy financial demands is a decelerated pace of technological integration and restricted patient access to highly effective surgical treatments. The steep price tag of sophisticated platforms is a direct reflection of the rigorous research and development efforts required to build them. As noted by AdvaMed, U.S. medical technology companies spent a minimum of $22.6 billion on research and development in 2024, highlighting the vast resources poured into creating these tools. These high creation expenses frequently lead to exorbitant purchase prices, presenting a continuous fiscal hurdle for medical providers and limiting the broader market growth of minimally invasive surgical equipment.
Market Trends
Incorporating artificial intelligence into surgical tools and preparation processes represents a crucial trend reshaping the minimally invasive surgical devices industry. By evaluating extensive data pools to formulate pre-surgery strategies and offer live assistance during operations, AI systems boost surgical accuracy, resulting in better operational workflows and clinical results. This transition transcends basic automation by introducing cognitive functions into surgical procedures, facilitating tailored patient treatment and smarter clinical choices. Highlighting major corporate backing in this advanced sector, Medtronic plc announced in September 2025 that it had expanded its London staff to more than 200, establishing its biggest worldwide digital hub focused on surgical robotics and AI.
At the same time, progress in augmented reality and 3D surgical imaging is vastly improving the visual resources available to medical professionals. These innovations deliver immersive perspectives of intricate anatomical structures, enabling highly precise tissue handling and navigation while keeping procedures minimally intrusive. Augmented reality platforms superimpose vital anatomical details and patient information directly onto the operating area, creating a heads-up display that reduces the necessity for surgeons to look away. This enhanced spatial understanding and visual sharpness help elevate surgical precision and can lead to decreased surgery durations. Illustrating this progress, Augmedics reported in April 2025 that 10,000 patients had been effectively treated utilizing its augmented reality surgical navigation platform, the xvision Spine System(R).
Report Scope
In this report, the Global Minimally Invasive Surgical Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Minimally Invasive Surgical Devices Market.
Global Minimally Invasive Surgical Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: